Posted by Jakeman on June 11, 2006, at 22:11:09
In reply to Re: EMSAM doses too low to effect depression ?, posted by notfred on June 11, 2006, at 21:08:36
What you are saying is in opposition to the studies conducted my Somerset and others which indicate that transdermal delivery by-passes first-pass metabolism resulting in higher exposure to selegline and less dietary restrictions as well as less exposure to metabolites. How are they wrong?
Warm regards, Jake
MSAM does not inhibit MAO-A at lower doses. This alone and not its transdermal delivery system accounts for the lack of dietary restrictions.
>
poster:Jakeman
thread:655515
URL: http://www.dr-bob.org/babble/20060610/msgs/655752.html